Porfiromycin Used as an Adjuvant to Radiation Therapy in Postoperative Head and Neck Cancer Patients
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Determination of efficacy and safety of porfiromycin versus placebo as an adjuvant to
radiotherapy in postoperative head and neck a cancer patients as well as assessment of
population pharmacokinetic parameters.